Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP26084.RASddQCq_FHqru21_uJFg-bsQPVt1YKZUg0wpph2q68NI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP26084.RASddQCq_FHqru21_uJFg-bsQPVt1YKZUg0wpph2q68NI130_assertion type Assertion NP26084.RASddQCq_FHqru21_uJFg-bsQPVt1YKZUg0wpph2q68NI130_head.
- NP26084.RASddQCq_FHqru21_uJFg-bsQPVt1YKZUg0wpph2q68NI130_assertion description "[Low-dose intermittent urokinase therapy in chronic symptomatic end-stage arterial disease--clinical relevance for patients with coronary artery disease or peripheral arterial occlusive disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP26084.RASddQCq_FHqru21_uJFg-bsQPVt1YKZUg0wpph2q68NI130_provenance.
- NP26084.RASddQCq_FHqru21_uJFg-bsQPVt1YKZUg0wpph2q68NI130_assertion evidence source_evidence_curated NP26084.RASddQCq_FHqru21_uJFg-bsQPVt1YKZUg0wpph2q68NI130_provenance.
- NP26084.RASddQCq_FHqru21_uJFg-bsQPVt1YKZUg0wpph2q68NI130_assertion SIO_000772 9181759 NP26084.RASddQCq_FHqru21_uJFg-bsQPVt1YKZUg0wpph2q68NI130_provenance.
- NP26084.RASddQCq_FHqru21_uJFg-bsQPVt1YKZUg0wpph2q68NI130_assertion wasDerivedFrom ctd_human-20150221 NP26084.RASddQCq_FHqru21_uJFg-bsQPVt1YKZUg0wpph2q68NI130_provenance.
- NP26084.RASddQCq_FHqru21_uJFg-bsQPVt1YKZUg0wpph2q68NI130_assertion wasGeneratedBy ECO_0000218 NP26084.RASddQCq_FHqru21_uJFg-bsQPVt1YKZUg0wpph2q68NI130_provenance.